Print

Print


Friday February 23  5:27 PM ET
System May Help Individualize Parkinson's Therapy
By Amy Norton
NEW YORK (Reuters Health) - Mapping brain responses to a
Parkinson's disease treatment known as deep brain stimulation
may help doctors tailor the therapy to individual patients'
needs, new research suggests.

Deep brain stimulation, or DBS, is typically used for patients
whose anti-Parkinson's drugs are failing to control their
tremors and movement problems. The tactic involves
implanting electrodes that discharge signals in particular
brain regions linked to the movement disorder. This calms the
brain overactivity that triggers Parkinson's symptoms.

In a new study, researchers used brain scans to link changes
in specific brain ``circuits'' to various improvements in
Parkinson's patients' symptoms. Such an understanding should
allow doctors to adjust individual patients' DBS treatment to
maximize their disease improvements, Dr. David Eidelberg of
North Shore University Hospital in Manhasset, New York,
explained in an interview with Reuters Health.

Eidelberg and his colleagues report their findings in the
February issue of the Annals of Neurology.

Eidelberg's team studied brain activity in six Parkinson's
patients who were being treated with DBS. The researchers
observed the patients as they performed simple reaching
movements. They found that overall, when patients' brain
stimulation was ``on,'' symptoms such as sluggish movement
improved. But the extent of patients' improvements varied,
and these variations were related to specific differences in
brain activity.

The hope for the future, according to Eidelberg, is to routinely
look at DBS patients' brain activity in order to tailor treatment--for
instance, adding more ``juice'' to a patient's electrical stimulation.

More than half a million Americans suffer from Parkinson's
disease, a movement disorder that over time can rob patients of
their ability to walk, speak and perform even simple tasks. The
exact cause remains a mystery, but the disease is marked by the
loss of the brain chemical dopamine, which helps regulate
movement.

Parkinson's treatments, including DBS, can help alleviate
symptoms caused by this dopamine loss.

SOURCE: Annals of Neurology

http://dailynews.yahoo.com/htx/nm/20010223/hl/parkinsons_1.html

***********